Cyndeo Wealth Partners’s Theratechnologies THTX Stock Holding History

Cyndeo Wealth Partners’s Portfolio THTX Stock Details THTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-47,498	Closed	-$152K	–	503
2025 Q3	$152K	Buy	47,498 +17,807	+60%	+$56.8K	0.01%	469
2025 Q2	$70.1K	Hold	29,691	–	–	﹤0.01%	461
2025 Q1	$41.6K	Buy	+29,691	New	+$49.6K	﹤0.01%	446
2024 Q4	–	Sell	-131,311	Closed	-$163K	–	463
2024 Q3	$163K	Buy	131,311 +27,191	+26%	+$36.8K	0.01%	435
2024 Q2	$146K	Buy	+104,120	New	+$138K	0.01%	385
2024 Q1	–	Sell	-104,120	Closed	-$169K	–	397
2023 Q4	$169K	Hold	104,120	–	–	0.02%	360
2023 Q3	$224K	Buy	+104,120	New	+$223K	0.02%	310

Cyndeo Wealth Partners's THTX Position: Q4 2025 in Review

Cyndeo Wealth Partners sold out of Theratechnologies (THTX) in Q4 2025, closing a stake of 47,498 shares — an estimated $152K sold.

Cyndeo Wealth Partners first reported a position in THTX in Q3 2023 and held it in 7 quarters. The position peaked at $224K in Q3 2023. 0 funds tracked by Wall St. Rank hold THTX as of Q4 2025.

Cyndeo Wealth Partners reported no remaining Theratechnologies position as of Q4 2025 after selling out during the quarter.
Cyndeo Wealth Partners sold 47,498 Theratechnologies shares in Q4 2025, an estimated $152K.
Cyndeo Wealth Partners first reported a position in Theratechnologies in Q3 2023 and held it in 7 quarters.
Cyndeo Wealth Partners's Theratechnologies position peaked at $224K in Q3 2023.
0 funds tracked by Wall St. Rank held Theratechnologies as of Q4 2025.

Based on Cyndeo Wealth Partners's 13F filing for Q4 2025, filed 7 Jan 2026.